Prazepam
From Wikipedia, the free encyclopedia
Prazepam
|
|
Systematic (IUPAC) name | |
9-chloro-2-(cyclopropylmethyl)-6-phenyl- 2,5-diazabicyclo[5.4.0]undeca- 5,8,10,12-tetraen-3-one |
|
Identifiers | |
CAS number | |
ATC code | N05 |
PubChem | ? |
DrugBank | |
Chemical data | |
Formula | C19H17ClN2O |
Mol. mass | 324.8 |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | Hepatic |
Half life | 36-200 hours |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status |
Schedule IV(US) |
Routes | Oral |
Prazepam (marketed under the trade name Centrax, in the U.S.) is a benzodiazepine derivative drug. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Also marketed under the name Lysanxia and DEMETRIN, the dosage is generally one 40mg tablet two or three times daily.
[edit] Side effects
- confusion
- depression
- lightheadedness or fainting spells
- mood changes, excitability or aggressive behavior
- movement difficulty, staggering or jerky movements
- muscle cramps
- restlessness
- tremors
- weakness or tiredness
- difficulty sleeping, nightmares
- dizziness, drowsiness, clumsiness, or unsteadiness; a "hangover" effect
- headache
- nausea, vomiting
[edit] External links
|
|